Genprex Stock Revenue
| GNPX Stock | USD 0.25 0.02 8.70% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Genprex's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year |
Genprex | Revenue | Build AI portfolio with Genprex Stock |
Genprex Company Revenue Analysis
Genprex's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Genprex
Projected quarterly revenue analysis of Genprex provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Genprex match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Genprex's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Genprex reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Genprex Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genprex's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genprex could also be used in its relative valuation, which is a method of valuing Genprex by comparing valuation metrics of similar companies.Genprex is currently under evaluation in revenue category among its peers.
Genprex Institutional Holders
Institutional Holdings refers to the ownership stake in Genprex that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Genprex's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Genprex's value.| Shares | Tower Research Capital Llc | 2025-03-31 | 6 K | Ifp Advisors, Llc | 2025-03-31 | 4.5 K | Sbi Securities Co Ltd | 2025-03-31 | 2.4 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 958 | Northwestern Mutual Wealth Management Co | 2025-03-31 | 512 | Bank Of America Corp | 2025-03-31 | 493 | Advisor Group Holdings, Inc. | 2025-03-31 | 148 | Hanson Mcclain Inc | 2025-03-31 | 125 | Group One Trading, Lp | 2025-03-31 | 114 | Geode Capital Management, Llc | 2025-03-31 | 83.7 K | Hightower Advisors, Llc | 2025-03-31 | 79.5 K |
Genprex Fundamentals
| Return On Equity | -3.07 | ||||
| Return On Asset | -1.29 | ||||
| Current Valuation | 4.4 M | ||||
| Shares Outstanding | 33.47 M | ||||
| Shares Owned By Insiders | 0.33 % | ||||
| Shares Owned By Institutions | 1.41 % | ||||
| Number Of Shares Shorted | 834.43 K | ||||
| Price To Earning | (1.09) X | ||||
| Price To Book | 2.04 X | ||||
| EBITDA | (21.1 M) | ||||
| Net Income | (21.11 M) | ||||
| Cash And Equivalents | 25.52 M | ||||
| Cash Per Share | 0.53 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 1.11 % | ||||
| Current Ratio | 10.71 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (17.15 M) | ||||
| Short Ratio | 0.24 X | ||||
| Earnings Per Share | (1.74) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 15 | ||||
| Beta | -0.48 | ||||
| Market Capitalization | 7.73 M | ||||
| Total Asset | 4.12 M | ||||
| Retained Earnings | (154.8 B) | ||||
| Working Capital | (426.7 K) | ||||
| Current Asset | 964.42 K | ||||
| Current Liabilities | 587.7 K | ||||
| Net Asset | 4.12 M |
About Genprex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genprex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genprex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genprex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genprex Stock Analysis
When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.